Octagen and Emory are parties to an agreement, pursuant to which Octagen is the exclusive, worldwide licensee of recombinant porcine factor VIII and low immunogenic factor VIII.
• Ipsen
Octagen and Ipsen are parties to an agreement, pursuant to which Ipsen is the worldwide sublicensee of recombinant porcine factor VIII.
© 2003-2005. Octagen Corporation. Legal Notice